UBS Asset Management Singapore

Targeting US$610 billion longevity market, biotech firms race to reverse ageing

Targeting US$610 billion longevity market, biotech firms race to reverse ageing AI is transforming longevity as companies like METiS TechBio and Human Longevity use algorithms to combat ageing and predict health risks “Those errors can be reprogrammed. It becomes possible to use AI to read, rewrite and reverse cells, or at least slow the ageing process,” Lai said in an interview with the South China Morning Post.